Definitive Contract 75A50121C00087

Award Date 9/20/21
Potential Completion Date 3/31/24
Potential Value $749K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98102, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
30
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a $748,885 firm-fixed-price contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute based in Seattle, Washington. The contract is for research and development of intranasal administration of RNA vaccines against respiratory pathogens.

The contract was awarded under an Ease Broad Agency Announcement (EZ-BAA) issued by the Division of Research, Innovation, and Ventures (DRIVe) within ASPR's Biomedical Advanced Research and Development Authority (BARDA). The EZ-BAA solicited proposals for areas of interest related to biomedical advanced research and development.

As part of the contract, AAHI has issued a $75,000 subcontract to Colorado State University's Sponsored Programs division to conduct a challenge study in ferrets to evaluate vaccines and adjuvants provided by AAHI. There is no set-aside designation indicated for this award.

Generated 10/11/24, 9:23 AM